The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Abstract
Antibody–drug conjugates are a very promising class of new anticancer agents, but the use of small‐molecule ligands for the targeted delivery of cytotoxic drugs into solid tumors is less well established. Here, we describe the first small‐molecule drug conjugates for the treatment of carbonic anhydrase IX expressing solid tumors. Using ligand–dye conjugates we demonstrate that such molecules can preferentially accumulate inside antigen‐positive lesions, have fast targeting kinetics and good tumor‐penetrating properties, and are easily accessible by total synthesis. A disulfide‐linked drug conjugate with the maytansinoid DM1 as the cytotoxic payload and a derivative of acetazolamide as the targeting ligand exhibited a potent antitumor effect in SKRC52 renal cell carcinoma in vivo. It was furthermore superior to sunitinib and sorafenib, both small‐molecule standard‐of‐care drugs for the treatment of kidney cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.055 · Cited by 548
Antibody Conjugate Therapeutics: Challenges and Potential
Teicher, B. A., & Chari, R. V. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1417 · Cited by 427
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Thiry, A., Dogné, J.-M., Masereel, B., & Supuran, C. T. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.002 · Cited by 395
Self-citationBorsi, L., Balza, E., Bestagno, M., Castellani, P., Carnemolla, B., Biro, A., Leprini, A., Sepulveda, J., Burrone, O., Neri, D., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10662 · Cited by 355
Self-citationTargeted drug delivery for cancer therapy: the other side of antibodies
Firer, M. A., & Gellerman, G. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-70 · Cited by 269
Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent
Dennis, M. S., Jin, H., Dugger, D., Yang, R., McFarland, L., Ogasawara, A., Williams, S., Cole, M. J., Ross, S., & Schwall, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2531 · Cited by 251
In Situ Click Chemistry: Enzyme‐Generated Inhibitors of Carbonic Anhydrase II
Mocharla, V. P., Colasson, B., Lee, L. V., Röper, S., Sharpless, K. B., Wong, C., & Kolb, H. C. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461580 · Cited by 242
Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic
Vlahov, I. R., & Leamon, C. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2005522 · Cited by 240
McIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239
Zolot, R. S., Basu, S., & Million, R. P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3980 · Cited by 227
Hussain, S. A., Ganesan, R., Reynolds, G., Gross, L., Stevens, A., Pastorek, J., Murray, P. G., Perunovic, B., Anwar, M. S., Billingham, L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603530 · Cited by 194
Kularatne, S. A., Wang, K., Santhapuram, H.-K. R., & Low, P. S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900069d · Cited by 191
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Small Targeted Cytotoxics: Current State and Promises from DNA‐Encoded Chemical Libraries
Krall, N., Scheuermann, J., & Neri, D. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201204631 · Cited by 148
Self-citationFunction of carbonic anhydrase IX in glioblastoma multiforme
Proescholdt, M. A., Merrill, M. J., Stoerr, E.-M., Lohmeier, A., Pohl, F., & Brawanski, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos216 · Cited by 139
A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy
Bernardes, G. J. L., Casi, G., Trüssel, S., Hartmann, I., Schwager, K., Scheuermann, J., & Neri, D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201106527 · Cited by 133
Self-citationAhlskog, J., Schliemann, C., Mårlind, J., Qureshi, U., Ammar, A., Pedley, R. B., & Neri, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605200 · Cited by 110
Self-citationCytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.
Li, L. H., DeKoning, T. F., Kelly, R. C., Krueger, W. C., McGovren, J. P., Padbury, G. E., Petzold, G. L., Wallace, T. L., Ouding, R. J., & Prairie, M. D. (1992) · PubMed · Cited by 109
Carta, F., Garaj, V., Maresca, A., Wagner, J. M., Avvaru, B. S., Robbins, A. H., Scozzafava, A., McKENNA, R. V., & Supuran, C. T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.005 · Cited by 100
Self-citationDesign of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
Sun, X., Widdison, W. C., Mayo, M., Wilhelm, S. D., Leece, B. A., Chari, R. V. J., Singh, R., & Erickson, H. K. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100498q · Cited by 93
Shiga Toxin‐Mediated Retrograde Delivery of a Topoisomerase I Inhibitor Prodrug
Alaoui, A. E., Schmidt, F., Amessou, M., Sarr, M., Decaudin, D., Florent, J., & Johannes, L. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701270 · Cited by 92
Takáčová, M., Bartošová, M., Škvarková, L., Zaťovičová, M., Vidličková, I., Csáderová, L., Baráthová, M., Breza, J., Jr., Bujdák, P., Pastorek, J., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.1001 · Cited by 71
Frey, K., Schliemann, C., Schwager, K., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.07.030 · Cited by 69
In Situ Click Chemistry: Enzyme‐Generated Inhibitors of Carbonic Anhydrase II
Mocharla, V. P., Colasson, B., Lee, L. V., Röper, S., Sharpless, K. B., Wong, C., & Kolb, H. C. (2004) · Angewandte Chemie · doi:10.1002/ange.200461580 · Cited by 60
Immunogenicity Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab Emtansine
Carrasco‐Triguero, M., Yi, J., Dere, R. C., Qiu, Z. J., Lei, C., Li, Y., Mahood, C., Wang, B., Leipold, D. D., Poon, K. A., et al. (2013) · Bioanalysis · doi:10.4155/bio.13.64 · Cited by 57
Xu, C., Lo, A. S., Yammanuru, A., Tallarico, A. S. C., Brady, K. W., Murakami, A., Barteneva, N. S., Zhu, Q. K., & Marasco, W. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009625 · Cited by 47
Askoxylakis, V., Boy, R. G., Rana, S., Krämer, S., Hebling, U., Mier, W., Altmann, A., Markert, A., Debus, J., & Haberkorn, U. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015962 · Cited by 38
Fourth World Antibody-Drug Conjugate Summit
Beck, A., Lambert, J. M., Sun, M. M. C., & Lin, K. (2012) · mAbs · doi:10.4161/mabs.21697 · Cited by 36
Schuster, H., Krewer, B., von Hof, J. M., Schmuck, K., Schuberth, I., Alves, F., & Tietze, L. F. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/b925070k · Cited by 35
Maresca, A., Carta, F., Vullo, D., Scozzafava, A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.088 · Cited by 31
Self-citationA Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy
Bernardes, G. J. L., Casi, G., Trüssel, S., Hartmann, I., Schwager, K., Scheuermann, J., & Neri, D. (2011) · Angewandte Chemie · doi:10.1002/ange.201106527 · Cited by 27
Self-citationLiu, Z., Floss, H. G., Cassady, J. M., & Chan, K. K. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.800 · Cited by 25
Krall, N., Scheuermann, J., & Neri, D. (2013) · Angewandte Chemie · doi:10.1002/ange.201204631 · Cited by 23
Self-citation
Cited by
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Advances in targeting the folate receptor in the treatment/imaging of cancers
Fernández, M., Javaid, F., & Chudasama, V. (2018) · Chemical Science · doi:10.1039/c7sc04004k · Cited by 539
Supuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G. (2018) · Medicinal Research Reviews · doi:10.1002/med.21497 · Cited by 253
Self-citationDal Corso, A., Gébleux, R., Murer, P., Soltermann, A., & Neri, D. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.040 · Cited by 75
Self-citation
Metadata
- Authors
- Krall, N., Pretto, F., Decurtins, W., Bernardes, G. J. L., Supuran, C. T., & Neri, D.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-03-12
- Volume
- 53
- Issue
- 16
- Pages
- 4231-4235
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2082259677
- Cited by
- 299
- References
- 35
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.